These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32231736)

  • 1. Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy.
    Feng W; Huang M; Zhao X; Chen S; Wang C; Chang J; Guo W; Chen Z; Zhu H; Zhu X
    J Cancer; 2020; 11(11):3310-3317. PubMed ID: 32231736
    [No Abstract]   [Full Text] [Related]  

  • 2. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
    Park HS; Kim HS; Beom SH; Rha SY; Chung HC; Kim JH; Chun YJ; Lee SW; Choe EA; Heo SJ; Noh SH; Hyung WJ; Cheong JH; Kim HI; Son T; Lim JS; Baek SE; Jung M
    Ann Surg Oncol; 2018 Oct; 25(11):3222-3230. PubMed ID: 30051367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Body Composition During Adjuvant FOLFOX Chemotherapy and Overall Survival in Non-Metastatic Colon Cancer.
    Chung E; Lee HS; Cho ES; Park EJ; Baik SH; Lee KY; Kang J
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study.
    Takeuchi M; Ishii K; Seki H; Yasui N; Sakata M; Shimada A; Matsumoto H
    BMC Surg; 2016 Aug; 16(1):54. PubMed ID: 27494994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
    Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
    Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Impact of Subcutaneous and Visceral Fat on Bone Changes after Gastrectomy.
    Cho S; Shin S; Lee S; Rhee Y; Kim HI; Hong N
    Endocrinol Metab (Seoul); 2024 Jul; ():. PubMed ID: 39015029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.
    Liu R; Huang M; Zhao X; Peng W; Sun S; Cao J; Ji D; Wang C; Guo W; Li J; Yin J; Zhu X
    Oncotarget; 2015 Nov; 6(36):39018-27. PubMed ID: 26528696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.
    Tang W; Liu X; Qiu L; Zhao X; Huang M; Yin J; Li J; Guo W; Zhu X; Chen Z
    Oncol Lett; 2018 Jan; 15(1):1334-1342. PubMed ID: 29399184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
    Geng R; Chen Z; Zhao X; Qiu L; Liu X; Liu R; Guo W; He G; Li J; Zhu X
    PLoS One; 2014; 9(12):e116027. PubMed ID: 25545243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism.
    Hong N; Lee J; Ku CR; Han K; Lee CR; Kang SW; Rhee Y
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):267-276. PubMed ID: 30428502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
    Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
    Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral obesity, muscle mass and outcome in rectal cancer surgery after neo-adjuvant chemo-radiation.
    Heus C; Cakir H; Lak A; Doodeman HJ; Houdijk AP
    Int J Surg; 2016 May; 29():159-64. PubMed ID: 27063857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.
    Saeki I; Yamasaki T; Maeda M; Kawano R; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
    Liver Cancer; 2018 Oct; 7(4):359-371. PubMed ID: 30488024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy.
    Wang SL; Ma LL; Chen XY; Zhou DL; Li B; Huang DD; Yu Z; Shen X; Zhuang CL
    Eur J Clin Nutr; 2018 Mar; 72(3):436-445. PubMed ID: 29184135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
    Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.
    Slaughter KN; Thai T; Penaroza S; Benbrook DM; Thavathiru E; Ding K; Nelson T; McMeekin DS; Moore KN
    Gynecol Oncol; 2014 Apr; 133(1):11-5. PubMed ID: 24680585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
    Nattenmüller J; Wochner R; Muley T; Steins M; Hummler S; Teucher B; Wiskemann J; Kauczor HU; Wielpütz MO; Heussel CP
    PLoS One; 2017; 12(1):e0169136. PubMed ID: 28107410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
    Miyamoto Y; Oki E; Emi Y; Tokunaga S; Shimokawa M; Ogata Y; Akagi Y; Sakamoto Y; Tanaka T; Saeki H; Maehara Y; Baba H
    Anticancer Res; 2018 Jan; 38(1):491-499. PubMed ID: 29277814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of visceral fat on laparoscopy-assisted distal gastrectomy.
    Miyaki A; Imamura K; Kobayashi R; Takami M; Matsumoto J
    Surgeon; 2013 Apr; 11(2):76-81. PubMed ID: 22840236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.